Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Navan, Inc.CL A(NAVN) | 27,195,364 | 28,218,676 | +1,023,312 | $464.50M | $373.62M | 28.95% | -$90.88M |
| Figma, Inc.CL A(FIG) | 16,246,129 | 16,011,378 | -234,751 | $607.12M | $338.48M | 26.23% | -$268.64M |
| Meta Platforms, Inc.CL A(META) | 212,531 | 212,531 | 0 | $140.29M | $121.60M | 9.42% | -$18.69M |
| Revolution Medicines, Inc.(RVMD) | 921,099 | 921,099 | 0 | $73.37M | $89.58M | 6.94% | +$16.21M |
| Nautilus Biotechnology, Inc.(NAUT) | 17,653,917 | 17,653,917 | 0 | $34.43M | $68.50M | 5.31% | +$34.07M |
| Block, Inc.CL A(XYZ) | 1,016,697 | 1,016,697 | 0 | $66.18M | $61.18M | 4.74% | -$4.99M |
| BioAge Labs, Inc.(BIOA) | 3,233,170 | 3,233,170 | 0 | $44.07M | $56.55M | 4.38% | +$12.48M |
| Maze Therapeutics, Inc.(MAZE) | 1,702,225 | 1,702,225 | 0 | $70.52M | $50.81M | 3.94% | -$19.71M |
| Erasca, Inc.(ERAS) | 2,862,500 | 2,862,500 | 0 | $10.65M | $46.32M | 3.59% | +$35.67M |
| Damora Therapeutics, Inc.(DMRA) | 0 | 1,236,157 | +1,236,157 | $0 | $32.02M | 2.48% | +$32.02M |
| Omada Health, Inc.(OMDA) | 3,460,929 | 2,307,284 | -1,153,645 | $54.61M | $29.00M | 2.25% | -$25.61M |
| CAMP4 THERAPEUTICS CORPORATION(CAMP) | 2,125,339 | 2,125,339 | 0 | $13.03M | $9.37M | 0.73% | -$3.66M |
| Aktis Oncology, Inc.(AKTS) | 0 | 415,000 | +415,000 | $0 | $7.42M | 0.58% | +$7.42M |
| Bitgo Holdings IncCL A | 0 | 666,356 | +666,356 | $0 | $5.48M | 0.42% | +$5.48M |
| Ginkgo Bioworks Holdings, Inc.CL A(DNA) | 108,568 | 108,568 | 0 | $902.2K | $665.5K | 0.05% | -$236.7K |
| Ip Strategy Holdings Inc COM | 0 | 82,740 | +82,740 | $0 | $21.8K | 0.00% | +$21.8K |
| Heritage Comm Corp | 82,740 | 0 | -82,740 | $129.1K | $0 | — | -$129.1K |